Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

NCT00673439 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped study terminated due to low accrual

Conditions

Interventions

Sponsor

University of Louisville

Collaborators